SARCOMAS
Clinical trials for SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SARCOMAS trials appear
Sign up with your email to follow new studies for SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough sarcomas in kids and adults
Disease control Recruiting nowThis early-stage study is testing whether combining two drugs, cabozantinib and high-dose ifosfamide, is safe and effective for people with sarcomas (a type of cancer) that have returned or not responded to standard treatment. About 30 children and adults will take part. The main…
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New cancer drug ZL-6201 enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug called ZL-6201 in adults with sarcoma or certain solid tumors that have spread or cannot be removed by surgery. The main goal is to check the drug's safety and find the right dose. About 180 people will take part in this study.
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug combo aims to ease pain after leg amputation
Symptom relief Recruiting nowThis study compares two pain relief methods during spinal anesthesia for above-knee amputation due to lower leg sarcoma. One group gets a standard painkiller (fentanyl) plus an extra drug (dexmedetomidine), while the other gets fentanyl alone. The goal is to see if the combinatio…
Matched conditions: SARCOMAS
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC